Free Trial
NASDAQ:ARAY

Accuray (ARAY) Stock Price, News & Analysis

Accuray logo
$1.31 +0.01 (+0.77%)
Closing price 04:00 PM Eastern
Extended Trading
$1.31 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Accuray Stock (NASDAQ:ARAY)

Key Stats

Today's Range
$1.30
$1.32
50-Day Range
$1.22
$1.59
52-Week Range
$1.14
$2.95
Volume
350,063 shs
Average Volume
644,559 shs
Market Capitalization
$147.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Accuray Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

ARAY MarketRank™: 

Accuray scored higher than 60% of companies evaluated by MarketBeat, and ranked 634th out of 1,841 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Accuray.

  • Earnings Growth

    Earnings for Accuray are expected to grow by 1,100.00% in the coming year, from $0.01 to $0.12 per share.

  • Price to Book Value per Share Ratio

    Accuray has a P/B Ratio of 2.91. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Accuray's valuation and earnings.
  • Percentage of Shares Shorted

    2.51% of the outstanding shares of Accuray have been sold short.
  • Short Interest Ratio / Days to Cover

    Accuray has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Accuray has recently decreased by 2.08%, indicating that investor sentiment is improving.
  • Dividend Yield

    Accuray does not currently pay a dividend.

  • Dividend Growth

    Accuray does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.51% of the outstanding shares of Accuray have been sold short.
  • Short Interest Ratio / Days to Cover

    Accuray has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Accuray has recently decreased by 2.08%, indicating that investor sentiment is improving.
  • News Sentiment

    Accuray has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Accuray this week, compared to 2 articles on an average week.
  • Search Interest

    8 people have searched for ARAY on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Accuray insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.23% of the stock of Accuray is held by insiders.

  • Percentage Held by Institutions

    64.08% of the stock of Accuray is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Accuray's insider trading history.
Receive ARAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Accuray and its competitors with MarketBeat's FREE daily newsletter.

ARAY Stock News Headlines

GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.
Accuray Director Makes Bold Stock Purchase!
See More Headlines

ARAY Stock Analysis - Frequently Asked Questions

Accuray's stock was trading at $1.98 at the beginning of the year. Since then, ARAY stock has decreased by 33.8% and is now trading at $1.31.

Accuray Incorporated (NASDAQ:ARAY) issued its earnings results on Wednesday, April, 30th. The medical equipment provider reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.05) by $0.04. The medical equipment provider had revenue of $113.24 million for the quarter, compared to analysts' expectations of $101.53 million. Accuray had a net margin of 0.14% and a trailing twelve-month return on equity of 1.43%.
Read the conference call transcript
.

Accuray subsidiaries include Morphormics Inc., TomoTherapy Incorporated, Accuray Accelerator Technology (Chengdu) Company Limited, Accuray Asia Ltd., Accuray Belgium BVBA, Accuray Brasil Comércio, Accuray Cayman Islands, and others.

Accuray's top institutional shareholders include North Star Investment Management Corp. (1.16%), Kovack Advisors Inc. (0.96%), Silverberg Bernstein Capital Management LLC (0.56%) and Williams & Novak LLC (0.07%). Insiders that own company stock include Suzanne C Winter, Sandeep Chalke, Joseph E Whitters, Jesse Chew, Michael Hoge, Ali Pervaiz, Patrick Spine and Gina Corradetti.
View institutional ownership trends
.

Shares of ARAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Accuray investors own include Waste Connections (WCN), American Water Works (AWK), Voyager Therapeutics (vygr), AU Optronics (AUOTY), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
4/30/2025
Today
8/06/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ARAY
CIK
1138723
Employees
1,040
Year Founded
1990

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.55 million
Net Margins
0.14%
Pretax Margin
0.63%
Return on Equity
1.43%
Return on Assets
0.14%

Debt

Debt-to-Equity Ratio
3.35
Current Ratio
1.64
Quick Ratio
0.92

Sales & Book Value

Annual Sales
$446.55 million
Price / Sales
0.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
2.91

Miscellaneous

Outstanding Shares
112,640,000
Free Float
107,879,000
Market Cap
$147.56 million
Optionable
Optionable
Beta
1.24

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ARAY) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners